FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hugo ten Cate

Research Profile

Physiology

Chemicals & Drugs

Disorders

Living Beings

Co-author Network

Publications

TOP 3
Kristien Winckers; Hugo ten Cate; Tilman M Hackeng
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.
Julian I. Borissoff; Mat J A P Daemen; Jay L Degen; Charles T Esmon; Tilman M Hackeng; Karly Hamulyák; Sylvia Heeneman; Peter Leenders; Sarah T B G Loubele; Jeroen J T Otten; Oliver Soehnlein; Henri M H Spronk; René Van Oerle; Joanne van Ryn; Hartmut Weiler; Erik A L Biessen; Hugo ten Cate
Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.
Pieter Eijgenraam; Hugo ten Cate; Arina Ten Cate-Hoek
Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hugo ten Cate (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kristien Winckers; Hugo ten Cate; Tilman M Hackeng
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.
Blood reviews 2013;27(3):119-32.
2013: Julian I. Borissoff; Mat J A P Daemen; Jay L Degen; Charles T Esmon; Tilman M Hackeng; Karly Hamulyák; Sylvia Heeneman; Peter Leenders; Sarah T B G Loubele; Jeroen J T Otten; Oliver Soehnlein; Henri M H Spronk; René Van Oerle; Joanne van Ryn; Hartmut Weiler; Erik A L Biessen; Hugo ten Cate
Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.
PloS one 2013;8(2):e55784.
2013: Pieter Eijgenraam; Hugo ten Cate; Arina Ten Cate-Hoek
Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis.
Current pharmaceutical design 2013;19(22):4014-23.
2012: Julian I. Borissoff; Ivo A Joosen; Henri M H Spronk; Hugo ten Cate; Mathijs O Versteylen; Leonard Hofstra
Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis.
JACC. Cardiovascular imaging 2012;5(12):1201-10.
2012: R Loeffen; S T B G Loubele; P H M Pluijmen; D Fens; M-C F Kleinegris; Hugo ten Cate; René Van Oerle; Henri M H Spronk
Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method.
Journal of thrombosis and haemostasis : JTH 2012;10(12):2544-54.
2012: Irma L A Geenen; Jos G Maessen; Daniel G M Molin; Mark J Post; Geert Willem H Schurink; Hugo ten Cate; Rene van Oerle; Henri M H Spronk
Coagulation on endothelial cells: the underexposed part of Virchow's Triad.
Thrombosis and haemostasis 2012;108(5):863-71.
2012: K Winckers; K C M M Beekers; P Erkens; Karly Hamulyák; Hugo ten Cate; A J Ten Cate-Hoek; Tilman M Hackeng
Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2012;10(10):2208-11.
2012: Marcus D Lancé; Marco A E Marcus; Matthijs Sloep; Henri M H Spronk; Hugo ten Cate; René Van Oerle; Gerhardus J A J M Kuiper; Yvonne M C Henskens
The effects of pneumatic tube system transport on ROTEM analysis and contact activation assessed by thrombin generation test.
Thrombosis research 2012;130(3):e147-50.
2012: R Loeffen; Henri M H Spronk; Hugo ten Cate
The impact of blood coagulability on atherosclerosis and cardiovascular disease.
Journal of thrombosis and haemostasis : JTH 2012;10(7):1207-16.
2012: Paola E J van der Meijden; René Van Oerle; M Van Schilfgaarde; Thomas Renné; Hugo ten Cate; Henri M H Spronk
Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.
Journal of thrombosis and haemostasis : JTH 2012;10(7):1355-62.
2012: Erfan Nur; Hans-Martin Otten; Ronald P J Oude Elferink; John-John B Schnog; Tom Teerlink; Hugo ten Cate; Bart J Biemond; Dees P Brandjes; Ashley J Duits; Ludo M Evers; Frits Muskiet
N-acetylcysteine reduces oxidative stress in sickle cell patients.
Annals of hematology 2012;91(7):1097-105.
2012: Petra M G Erkens; Harry R Büller; Hugo ten Cate; Martin H Prins
Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.
PloS one 2012;7(9):e42269.
2011: K Winckers; A Algra; Elisabetta Castoldi; C Duckers; Tilman M Hackeng; L F Maurissen; B Siegerink; Henri M H Spronk; Guido Tans; Hugo ten Cate; Frits R Rosendaal
Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study.
Journal of thrombosis and haemostasis : JTH 2011;9(11):2243-50.
2011: Joke Konings; Sumitra Mohan; Nicola J Mutch; Helen Philippou; Guido Tans; Hugo ten Cate; Peter Allan; Julian I. Borissoff; José W P Govers-Riemslag; Robert A S Ariëns
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.
Blood 2011;118(14):3942-51.
2011: Julian I. Borissoff; Hugo ten Cate
From neutrophil extracellular traps release to thrombosis: an overshooting host-defense mechanism?
Journal of thrombosis and haemostasis : JTH 2011;9(9):1791-4.
2011: E Kilinç; C Oschatz; Thomas Renné; T Sandström; Julian I. Borissoff; F R Cassee; Miriam E Gerlofs-Nijland; N A Janssen; Hugo ten Cate; René Van Oerle; Henri M H Spronk
Factor XII activation is essential to sustain the procoagulant effects of particulate matter.
Journal of thrombosis and haemostasis : JTH 2011;9(7):1359-67.
2011: Renée A Douma; Marc F Durian; Petra M G Erkens; Herman M A Hofstee; Marcel M Hovens; Menno V Huisman; Pieter W Kamphuisen; Frederikus A Klok; Inge C M Mos; Tessa A C Nizet; Hugo ten Cate; Erik F Ullmann; Anja A van Houten; Harry R Büller
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study.
Annals of internal medicine 2011;154(11):709-18.
2011: Julian I. Borissoff; Henri M H Spronk; Hugo ten Cate
The hemostatic system as a modulator of atherosclerosis.
The New England journal of medicine 2011;364(18):1746-60.
2011: M Smid; A W J H Dielis; M Winkens; Henri M H Spronk; René Van Oerle; Karly Hamulyák; Martin H Prins; Jan Rosing; J L Waltenberger; Hugo ten Cate
Thrombin generation in patients with a first acute myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2011;9(3):450-6.
2011: Evren Kilinç; Holger Schulz; Gerhardus Jajm Kuiper; Henri Mh Spronk; Hugo ten Cate; Swapna Upadhyay; Koustav Ganguly; Tobias Stoeger; Manuela Semmler-Bhenke; Shinji Takenaka; Wolfgang G Kreyling; Mike Pitz; Peter Reitmeir; Annette Peters; Oliver Eickelberg; H-Erich Wichmann
The procoagulant effects of fine particulate matter in vivo.
Particle and fibre toxicology 2011;8():12; author reply 12.
2010: Yesim Dargaud; Henri M H Spronk; Peter Leenders; H Coenraad Hemker; Hugo ten Cate
Monitoring platelet dependent thrombin generation in mice.
Thrombosis research 2010;126(5):436-41.
2010: Julian I. Borissoff; Sylvia Heeneman; Evren Kilinç; Peter Kassák; René Van Oerle; Kristien Winckers; José W P Govers-Riemslag; Karly Hamulyák; Tilman M Hackeng; Mat J A P Daemen; Hugo ten Cate; Henri M H Spronk
Early atherosclerosis exhibits an enhanced procoagulant state.
Circulation 2010;122(8):821-30.
2010: Arina J Ten Cate-Hoek; Hugo ten Cate; Jan Tordoir; Karly Hamulyák; Martin H Prins
Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome.
Journal of vascular surgery 2010;52(1):132-8.
2010: Roger J M W Rennenberg; Bernard J van Varik; Leon J Schurgers; Karly Hamulyak; Hugo ten Cate; Tim Leiner; Cees Vermeer; Peter W de Leeuw; Abraham A Kroon
Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans.
Blood 2010;115(24):5121-3.
2010: Willeke Wisse; Maaike Boer Rookhuizen; Martijn D de Kruif; Janny van Rossum; Inge Jordans; Hugo ten Cate; Luc J C van Loon; Eelco W Meesters
Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients.
Diabetes research and clinical practice 2010;88(2):e10-3.
2010: Martijn D de Kruif; Maarten Limper; Herman Gerritsen; C Arnold Spek; D P M Brandjes; Hugo ten Cate; Patrick M Bossuyt; Pieter H Reitsma; Eric C M van Gorp
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.
Critical care medicine 2010;38(2):457-63.
2010: Lian Engelen; Isabel Ferreira; Katrien H J Gaens; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Leen M 't Hart; Marleen M J van Greevenbroek; Carla J H van der Kallen; Ellen E Blaak; Edith J M Feskens; Hugo ten Cate; Coen D A Stehouwer; Casper G Schalkwijk
The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studies.
Journal of hypertension 2010;28(2):285-93.
2010: S E M Schols; M D Lancé; Marion A H Feijge; J G M C Damoiseaux; M A Marcus; Karly Hamulyák; Hugo ten Cate; Johan W M Heemskerk; Elisabeth C M van Pampus
Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery.
Thrombosis and haemostasis 2010;103(2):318-28.
2010: Martijn D de Kruif; Maarten Limper; Karlien Sierhuis; Jiri F P Wagenaar; C Arnold Spek; Cecilia Garlanda; Alessia Cotena; Alberto Mantovani; Hugo ten Cate; Pieter H Reitsma; Eric C M van Gorp
PTX3 predicts severe disease in febrile patients at the emergency department.
The Journal of infection 2010;60(2):122-7.
2010: Ingeborg M Kooter; Miriam E Gerlofs-Nijland; john boere; Daan L A C Leseman; Paul H B Fokkens; Henri M H Spronk; Kim Frederix; Hugo ten Cate; Ad M Knaapen; Hendrik J Vreman; Flemming R Cassee
Diesel engine exhaust initiates a sequence of pulmonary and cardiovascular effects in rats.
Journal of toxicology 2010;2010():206057.
2010: Olivier Segers; René Van Oerle; Hugo ten Cate; Jan Rosing; Elisabetta Castoldi
Thrombin generation as an intermediate phenotype for venous thrombosis.
Thrombosis and haemostasis 2010;103(1):114-22.
2009: Eefje Jong; Susan Louw; Joost C M Meijers; Martijn D de Kruif; Hugo ten Cate; Harry R Büller; Jan Willem Mulder; Eric C M van Gorp
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy.
AIDS patient care and STDs 2009;23(12):1001-7.
2009: G Rudez; P Meijer; Henri M H Spronk; F W G Leebeek; Hugo ten Cate; Cornelis Kluft; M P M de Maat
Biological variation in inflammatory and hemostatic markers.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1247-55.
2009: Simone J H Wielders; Jos L V Broers; Hugo ten Cate; Peter W Collins; Edouard M Bevers; Theo Lindhout
Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
Thrombosis and haemostasis 2009;102(1):76-82.
2009: Lian Engelen; Isabel Ferreira; Olaf Brouwers; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Marleen M J van Greevenbroek; Carla J H van der Kallen; Ellen E Blaak; Edith J M Feskens; Hugo ten Cate; Coen D A Stehouwer; Casper G Schalkwijk
Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies.
Journal of hypertension 2009;27(7):1399-403.
2009: Sarah T B G Loubele; C Arnold Spek; Peter Leenders; René Van Oerle; Hella L Aberson; Karly Hamulyák; Gary Ferrell; Charles T Esmon; Henri M H Spronk; Hugo ten Cate
Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(7):1087-92.
2009: Goran Rudez; Nicole A H Janssen; Evren Kilinc; Frank W G Leebeek; Miriam E Gerlofs-Nijland; Henri M H Spronk; Hugo ten Cate; Flemming R Cassee; Moniek P M de Maat
Effects of ambient air pollution on hemostasis and inflammation.
Environmental health perspectives 2009;117(6):995-1001.
2009: S T B G Loubele; C A Spek; Peter Leenders; René Van Oerle; H L Aberson; Danny J M van der Voort; Karly Hamulyák; L C Petersen; Henri M H Spronk; Hugo ten Cate
Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in mice.
Journal of thrombosis and haemostasis : JTH 2009;7(2):290-8.
2009: Ester C Löwenberg; Arne W J H Dielis; Joost C M Meijers; Hugo ten Cate; Marcel Levi
[Better understanding of blood coagulation in vivo].
Nederlands tijdschrift voor geneeskunde 2009;153(1-2):30-7.
2008: Marina Marchetti; Elisabetta Castoldi; Henri M H Spronk; René Van Oerle; Donatella Balducci; Tiziano Barbui; Jan Rosing; Hugo ten Cate; Anna Falanga
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.
Blood 2008;112(10):4061-8.
2008: Hugo ten Cate; Karly Hamulyak
Rivaroxaban for thromboprophylaxis.
The New England journal of medicine 2008;359(20):2174-5; author reply 2176.
2008: Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
The Journal of clinical investigation 2008;118(9):3208-18.
2008: Arne W J H Dielis; Wolfgang M R Balliël; René Van Oerle; Wim T Hermens; Henri M H Spronk; Hugo ten Cate; Karly Hamulyák
Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A.
Haematologica 2008;93(9):1351-7.
2008: Henri M H Spronk; Arne W J H Dielis; Erik de Smedt; René Van Oerle; Diane Fens; Martin H Prins; Karly Hamulyák; Hugo ten Cate
Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory.
Thrombosis and haemostasis 2008;100(2):362-4.
2008: Erik de Smedt; Raed Al Dieri; Henri M H Spronk; Karli Hamulyak; Hugo ten Cate; Coenraad Hemker
The technique of measuring thrombin generation with fluorogenic substrates: 1. Necessity of adequate calibration.
Thrombosis and haemostasis 2008;100(2):343-9.
2008: Arina J ten Cate-Hoek; Arne W J H Dielis; Henri M H Spronk; René Van Oerle; Karly Hamulyák; Martin H Prins; Hugo ten Cate
Thrombin generation in patients after acute deep-vein thrombosis.
Thrombosis and haemostasis 2008;100(2):240-5.
2008: Kitty B J M Cleutjens; Birgit C G Faber; Mat Rousch; Ruben van Doorn; Tilman M Hackeng; Cornelis Vink; Piet Geusens; Hugo ten Cate; Johannes Waltenberger; Vadim Tchaikovski; Marc Lobbes; Veerle Somers; Anneke Sijbers; Darcey Black; Peter J E H M Kitslaar; Mat J A P Daemen
Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling.
The Journal of clinical investigation 2008;118(8):2979-85.
2008: Maarten F Bijlsma; Peter J A Leenders; Ben J A Janssen; Maikel Peppelenbosch; Hugo ten Cate; C Arnold Spek
Endogenous hedgehog expression contributes to myocardial ischemia-reperfusion-induced injury.
Experimental biology and medicine (Maywood, N.J.) 2008;233(8):989-96.
2008: Kim Frederix; Ingeborg M Kooter; René Van Oerle; Diane Fens; Karly Hamulyak; Miriam E Gerlofs-Nijland; Hugo ten Cate; Henri M H Spronk
A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance.
Thrombosis journal 2008;6():14.
2008: Arne W J H Dielis; Elisabetta Castoldi; Henri M H Spronk; René Van Oerle; Karly Hamulyák; Hugo ten Cate; Jan Rosing
Coagulation factors and the protein C system as determinants of thrombin generation in a normal population.
Journal of thrombosis and haemostasis : JTH 2008;6(1):125-31.
2007: Kim Frederix; Anil K Chauhan; Janka Kisucka; Bing-Qiao Zhao; Erik I Hoff; Henri M H Spronk; Hugo ten Cate; Denisa D Wagner
Platelet adhesion receptors do not modulate infarct volume after a photochemically induced stroke in mice.
Brain research 2007;1185():239-45.
2007: Johanna A Kremer-Hovinga; Sacha Zeerleder; P Kessler; Thalia Romani de Wit; Jan A van Mourik; C Erik Hack; Hugo ten Cate; Pieter H Reitsma; Walter A Wuillemin; Bernhard Lämmle
ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock.
Journal of thrombosis and haemostasis : JTH 2007;5(11):2284-90.
2007: Sjoukje H Slofstra; Maarten F Bijlsma; Angelique P Groot; Pieter H Reitsma; Theo Lindhout; Hugo ten Cate; C Arnold Spek
Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation.
Blood 2007;110(9):3176-82.
2007: Hjalmar R Hansen; Jef L Wolfs; Lois Bruggemann; Dirkje W Sommeijer; Eduard Bevers; Arnaud D Hauer; Johan Kuiper; C Arnold Spek; Henri M H Spronk; Pieter H Reitsma; Hugo ten Cate
Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(7):627-36.
2007: Sjoukje H Slofstra; Angelique P Groot; Maartje H P Obdeijn; Pieter H Reitsma; Hugo ten Cate; C Arnold Spek
Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation.
American journal of respiratory and critical care medicine 2007;176(6):602-9.
2007: José W P Govers-Riemslag; Machiel Smid; J A Cooper; K A Bauer; R D Rosenberg; C Erik Hack; Karly Hamulyak; Henri M H Spronk; G J Miller; Hugo ten Cate
The plasma kallikrein-kinin system and risk of cardiovascular disease in men.
Journal of thrombosis and haemostasis : JTH 2007;5(9):1896-903.
2007: S Bizzarro; Ubele van der Velden; J M A G ten Heggeler; E Leivadaros; Frans J Hoek; V E A Gerdes; Stephan J L Bakker; Rijk O B Gans; Hugo ten Cate; Bruno G Loos
Periodontitis is characterized by elevated PAI-1 activity.
Journal of clinical periodontology 2007;34(7):574-80.
2007: Arne W J H Dielis; Machiel Smid; Henri M H Spronk; A J H M Houben; Karly Hamulyák; Abraham A Kroon; Hugo ten Cate; Peter W de Leeuw
Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1509-15.
2007: J F P Wagenaar; Marga G A Goris; M S Sakundarno; M Hussein Gasem; Albert T A Mairuhu; Martijn D de Kruif; Hugo ten Cate; Rudy A Hartskeerl; D P M Brandjes; Eric C M van Gorp
What role do coagulation disorders play in the pathogenesis of leptospirosis?
Tropical medicine & international health : TM & IH 2007;12(1):111-22.
2007: Eelco W Meesters; Hjalmar Hansen; Henri M H Spronk; Karly Hamulyak; Jan Rosing; Ajda T Rowshani; Ineke J M ten Berge; Hugo ten Cate
The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(1):21-8.
2006: S Loubele; Hugo ten Cate
Local administration of recombinant human antithrombin in a mouse model of peritoneal sepsis.
Journal of thrombosis and haemostasis : JTH 2006;4(11):2340-2.
2006: Sjoukje H Slofstra; Hugo ten Cate; C Arnold Spek
Signal transduction induced by activated protein C: no role in protection against sepsis?
Trends in molecular medicine 2006;12(8):374-81.
2006: V E A Gerdes; Vincent I H Kwa; Hugo ten Cate; D P M Brandjes; Harry R Büller; Jan Stam
Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease.
Atherosclerosis 2006;186(1):166-72.
2006: Dirkje W Sommeijer; Hjalmar R Hansen; René Van Oerle; Karly Hamulyak; Anton P Van Zanten; E Meesters; Henri M H Spronk; Hugo ten Cate
Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes.
Journal of thrombosis and haemostasis : JTH 2006;4(3):574-80.
2006: Vivian de Waard; Hjalmar R Hansen; Henri H M Spronk; Janneke J Timmerman; Hans Pannekoek; Sandrine Florquin; Pieter H Reitsma; Hugo ten Cate
Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited.
Thrombosis and haemostasis 2006;95(2):348-53.
2006: Marcel Levi; Tom van der Poll; Hugo ten Cate
Tissue factor in infection and severe inflammation.
Seminars in thrombosis and hemostasis 2006;32(1):33-9.
2006: Sjoukje H Slofstra; Hugo ten Cate; C Arnold Spek
Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction.
Thrombosis journal 2006;4():13.
2006: Arnaud D Hauer; Paula de Vos; Niels Peterse; Hugo ten Cate; Theo Van berkel; Frank R M Stassen; Johan Kuiper
Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice.
Cardiovascular research 2006;69(1):280-8.
2005: Arne W J H Dielis; Machiel Smid; Henri M H Spronk; Karly Hamulyak; Abraham A Kroon; Hugo ten Cate; Peter W de Leeuw
The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems.
Hypertension 2005;46(6):1236-42.
2005: Albert T A Mairuhu; Tatty E Setiati; Penelope Koraka; C Erik Hack; A Leyte; S M H Faradz; Hugo ten Cate; D P M Brandjes; A D M E Osterhaus; P H Reitsma; Eric C M van Gorp
Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism.
Thrombosis journal 2005;3():17.
2005: Dirkje W Sommeijer; René Van Oerle; Pieter H Reitsma; Janneke J Timmerman; Joost C M Meijers; Henri M H Spronk; Hugo ten Cate
Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes.
Thrombosis journal 2005;3():12.
2005: Dirkje W Sommeijer; K Joop; A Leyte; Pieter H Reitsma; Hugo ten Cate
Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1168-71.
2005: Sjoukje H Slofstra; Cornelis van 't Veer; Wim A Buurman; Pieter H Reitsma; Hugo ten Cate; C Arnold Spek
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.
Critical care medicine 2005;33(6):1365-70.
2005: S K Klein; E J Slim; Martijn D de Kruif; Tymen T Keller; Hugo ten Cate; Eric C M van Gorp; D P M Brandjes
Is chronic HIV infection associated with venous thrombotic disease? A systematic review.
The Netherlands journal of medicine 2005;63(4):129-36.
2005: Martijn D de Kruif; Eric C M van Gorp; Tymen T Keller; Jacobus M Ossewaarde; Hugo ten Cate
Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
Cardiovascular research 2005;65(2):317-27.
2005: Roy F M van der Putten; Henk te Velthuis; Lucien A Aarden; Hugo ten Cate; Jan F C Glatz; Wim T Hermens
High-affinity antibodies in a new immunoassay for plasma tissue factor: reduction in apparent intra-individual variation.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(12):1386-91.
2005: Dirkje W Sommeijer; Sandrine Florquin; Inge Hoedemaker; Janneke J Timmerman; Pieter H Reitsma; Hugo ten Cate
Renal tissue factor expression is increased in streptozotocin-induced diabetic mice.
Nephron. Experimental nephrology 2005;101(3):e86-94.
2005: Efstratios Leivadaros; Ubele van der Velden; Sergio Bizzarro; Johanna M A G ten Heggeler; V E A Gerdes; Frans J Hoek; Thomas O M Nagy; Jose Scholma; Stephan J L Bakker; Rijk O B Gans; Hugo ten Cate; Bruno G Loos
A pilot study into measurements of markers of atherosclerosis in periodontitis.
Journal of periodontology 2005;76(1):121-8.
2004: JB Schnog; Ashley J Duits; Frits A J Muskiet; Hugo ten Cate; RA Rojer; D P M Brandjes
Sickle cell disease; a general overview.
The Netherlands journal of medicine 2004;62(10):364-74.
2004: Hugo ten Cate
The biphasic waveform in plasma: identifying the sepsis-coagulation crossroad?
Journal of thrombosis and haemostasis : JTH 2004;2(9):1533-4.
2004: Dirkje W Sommeijer; Aida Beganovic; Casper G Schalkwijk; Hanneke Ploegmakers; Chris M van der Loos; Benien E van Aken; Hugo ten Cate; Allard C van der Wal
More fibrosis and thrombotic complications but similar expression patterns of markers for coagulation and inflammation in symptomatic plaques from DM2 patients.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2004;52(9):1141-9.
2004: V E A Gerdes; Roderik A Kraaijenhagen; Esther W M Vogels; Hugo ten Cate; Pieter H Reitsma
Factor XI gene analysis in thrombophilia and factor XI deficiency.
Journal of thrombosis and haemostasis : JTH 2004;2(6):1015-7.
2004: JB Schnog; Melvin R Mac Gillavry; Anton P Van Zanten; Joost C M Meijers; RA Rojer; Ashley J Duits; Hugo ten Cate; D P M Brandjes
Protein C and S and inflammation in sickle cell disease.
American journal of hematology 2004;76(1):26-32.
2004: Hugo ten Cate
Blood coagulation in cystic fibrosis: modulating inflammation?
Journal of thrombosis and haemostasis : JTH 2004;2(4):555-6.
2004: V E A Gerdes; H A Kremer Hovinga; Hugo ten Cate; Melvin R MacGillavry; A Leijte; Pieter H Reitsma; D P M Brandjes; Harry R Büller
Homocysteine and markers of coagulation and endothelial cell activation.
Journal of thrombosis and haemostasis : JTH 2004;2(3):445-51.
2004: Anita W Rijneveld; Sebastiaan Weijer; Sandrine Florquin; Charles T Esmon; Joost C M Meijers; Peter Speelman; Pieter H Reitsma; Hugo ten Cate; Tom van der Poll
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide.
Blood 2004;103(5):1702-9.
2004: Dirkje W Sommeijer; Melvin R MacGillavry; Joost C M Meijers; Anton P Van Zanten; Pieter H Reitsma; Hugo ten Cate
Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes.
Diabetes care 2004;27(2):468-73.
2004: V E A Gerdes; Johanna A Kremer-Hovinga; Hugo ten Cate; D P M Brandjes; H R Büller
Soluble thrombomodulin in patients with established atherosclerosis.
Journal of thrombosis and haemostasis : JTH 2004;2(1):200-1.
2004: Johanna A Kremer-Hovinga; Rendrik F Franco; Marco Zago; Hugo ten Cate; Rudi G J Westendorp; Pieter H Reitsma
A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease.
Journal of thrombosis and haemostasis : JTH 2004;2(1):54-7.
2003: Henri M H Spronk; José W P Govers-Riemslag; Hugo ten Cate
The blood coagulation system as a molecular machine.
BioEssays : news and reviews in molecular, cellular and developmental biology 2003;25(12):1220-8.
2003: Janine Dörffler-Melly; Martijn D de Kruif; Lothar A Schwarte; Rendrik F Franco; Sandrine Florquin; C Arnold Spek; Can Ince; Pieter H Reitsma; Hugo ten Cate
Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis.
Basic research in cardiology 2003;98(6):347-52.
2003: Tymen T Keller; Albert T A Mairuhu; Martijn D de Kruif; Saskia K Klein; V E A Gerdes; Hugo ten Cate; D P M Brandjes; Marcel Levi; Eric C M van Gorp
Infections and endothelial cells.
Cardiovascular research 2003;60(1):40-8.
2003: Marcel Levi; Tymen T Keller; Eric C M van Gorp; Hugo ten Cate
Infection and inflammation and the coagulation system.
Cardiovascular research 2003;60(1):26-39.
2003: Willeke M C Jong; Pieter H Reitsma; Hugo ten Cate; Robbert J De Winter
Modified two-step model for studying the inflammatory response during myocardial ischemia and reperfusion in mice.
Comparative medicine 2003;53(5):522-6.
2003: Ashley J Duits; RA Rojer; T van Endt; Melvin R MacGillavry; Hugo ten Cate; D P M Brandjes; JB Schnog
Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease.
Annals of hematology 2003;82(3):171-4.
2003: V E A Gerdes; Roel P Verkooyen; Vincent I H Kwa; Eric de Groot; Eric C M van Gorp; Hugo ten Cate; D P M Brandjes; Harry R Büller
Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis.
Atherosclerosis 2003;167(1):65-71.
2003: JB Schnog; RA Rojer; Melvin R Mac Gillavry; Hugo ten Cate; D P M Brandjes; Ashley J Duits
Steady-state sVCAM-1 serum levels in adults with sickle cell disease.
Annals of hematology 2003;82(2):109-13.
2003: Sjoukje H Slofstra; C Arnold Spek; Hugo ten Cate
Disseminated intravascular coagulation.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(5):295-302.
2003: Albert T A Mairuhu; Melvin R Mac Gillavry; Tatty E Setiati; Augustinus Soemantri; Hugo ten Cate; D P M Brandjes; Eric C M van Gorp
Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence.
The Lancet infectious diseases 2003;3(1):33-41.
2002: JB Schnog; Melvin R Mac Gillavry; RA Rojer; Joost C M Meijers; R Fijnheer; Hugo ten Cate; D P M Brandjes; Ashley J Duits
No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease.
American journal of hematology 2002;71(1):53-5.
2002: V E A Gerdes; Hugo ten Cate; Eric de Groot; Vincent I H Kwa; Martin H Prins; Pieter H Reitsma; Harry R Büller; D P M Brandjes
Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis.
Atherosclerosis 2002;163(1):135-40.
2002: Willeke M C Jong; Coert J Zuurbier; Robbert J De Winter; Danyel A F Van Den Heuvel; Pieter H Reitsma; Hugo ten Cate; Can Ince
Fentanyl-fluanisone-midazolam combination results in more stable hemodynamics than does urethane alpha-chloralose and 2,2,2-tribromoethanol in mice.
Contemporary topics in laboratory animal science / American Association for Laboratory Animal Science 2002;41(3):28-32.
2002: Marcel Levi; Hugo ten Cate; Tom van der Poll
Endothelium: interface between coagulation and inflammation.
Critical care medicine 2002;30(5 Suppl):S220-4.
2001: Marcel Levi; Evert de Jonge; Tom van der Poll; Hugo ten Cate
Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies.
Seminars in thrombosis and hemostasis 2001;27(6):569-75.
2001: JB Schnog; Arnon P Kater; Melvin R Mac Gillavry; Ashley J Duits; LR Lard; Fey P L van der Dijs; D P M Brandjes; Hugo ten Cate; L W van Eps; RA Rojer
Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study.
American journal of hematology 2001;68(3):179-83.
2001: Hugo ten Cate; Saskia H H F Schoenmakers; R Franco; Janneke J Timmerman; Angelique P Groot; C Arnold Spek; Pieter H Reitsma
Microvascular coagulopathy and disseminated intravascular coagulation.
Critical care medicine 2001;29(7 Suppl):S95-7; discussion S97-8.
2001: Eric C M van Gorp; MC Minnema; Catharina Suharti; Albert T A Mairuhu; D P M Brandjes; Hugo ten Cate; C Erik Hack; Joost C M Meijers
Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever.
British journal of haematology 2001;113(1):94-9.
2000: MC Minnema; Ron J G Peters; Robbert J De Winter; Y P Lubbers; Samad Barzegar; Kenneth A Bauer; R D Rosenberg; C Erik Hack; Hugo ten Cate
Activation of clotting factors XI and IX in patients with acute myocardial infarction.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(11):2489-93.
2000: Marcel Levi; Evert de Jonge; Tom van der Poll; Hugo ten Cate
Novel approaches to the management of disseminated intravascular coagulation.
Critical care medicine 2000;28(9 Suppl):S20-4.
2000: Hugo ten Cate
Pathophysiology of disseminated intravascular coagulation in sepsis.
Critical care medicine 2000;28(9 Suppl):S9-11.
2000: Rendrik F Franco; Evert de Jonge; Pascale E P Dekkers; Janneke J Timmerman; C Arnold Spek; Sander J H van Deventer; P van Deursen; L van Kerkhoff; B van Gemen; Hugo ten Cate; Tom van der Poll; Pieter H Reitsma
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.
Blood 2000;96(2):554-9.
1999: MC Minnema; M E Wittekoek; N Schoonenboom; J J Kastelein; C Erik Hack; Hugo ten Cate
Activation of the contact system of coagulation does not contribute to the hemostatic imbalance in hypertriglyceridemia.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(10):2548-53.
1999: Marcel Levi; Hugo ten Cate
Disseminated intravascular coagulation.
The New England journal of medicine 1999;341(8):586-92.
1999: Hugo ten Cate; J J Timmerman; M Levi
The pathophysiology of disseminated intravascular coagulation.
Thrombosis and haemostasis 1999;82(2):713-7.
1999: Marcel Levi; Evert de Jonge; Tom van der Poll; Hugo ten Cate
Disseminated intravascular coagulation.
Thrombosis and haemostasis 1999;82(2):695-705.
1999: Eric C M van Gorp; Catharina Suharti; Hugo ten Cate; Wil M V Dolmans; Jos W M van der Meer; JW ten Cate; D P M Brandjes
Review: infectious diseases and coagulation disorders.
The Journal of infectious diseases 1999;180(1):176-86.
1999: MC Minnema; Hugo ten Cate; C Erik Hack
The role of factor XI in coagulation: a matter of revision.
Seminars in thrombosis and hemostasis 1999;25(4):419-28.
1999: Rendrik F Franco; MD Trip; Hugo ten Cate; A van den Ende; Martin H Prins; JJ Kastelein; Pieter H Reitsma
The 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease.
British journal of haematology 1999;104(1):50-4.
1998: A Manten; Robbert J De Winter; MC Minnema; Hugo ten Cate; J G Lijmer; R Adams; Ron J G Peters; Sander J H van Deventer
Procoagulant and proinflammatory activity in acute coronary syndromes.
Cardiovascular research 1998;40(2):389-95.
1998: MC Minnema; D Pajkrt; W A Wuillemin; D Roem; W K Bleeker; Marcel Levi; Sander J H van Deventer; C Erik Hack; Hugo ten Cate
Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.
Blood 1998;92(9):3294-301.
1998: Rendrik F Franco; Marco Zago; MD Trip; Hugo ten Cate; A van den Ende; Martin H Prins; JJ Kastelein; Pieter H Reitsma
Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease.
British journal of haematology 1998;102(5):1172-5.
1998: Marcel Levi; Tom van der Poll; Hugo ten Cate; B Kuipers; Bart J Biemond; Henk M Jansen; JW ten Cate
Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.
American journal of respiratory and critical care medicine 1998;158(1):92-8.
1998: MC Minnema; Philip W Friederich; Marcel Levi; Peter A von dem Borne; Laurent O Mosnier; Joost C M Meijers; Bart J Biemond; C Erik Hack; Bonno N Bouma; Hugo ten Cate
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.
The Journal of clinical investigation 1998;101(1):10-4.
1997: JW ten Cate; Tom van der Poll; Marcel Levi; Hugo ten Cate; Sander J H van Deventer
Cytokines: triggers of clinical thrombotic disease.
Thrombosis and haemostasis 1997;78(1):415-9.
1997: MC Minnema; Hugo ten Cate; Edwin J.R. van Beek; A van den Ende; C Erik Hack; D P M Brandjes
Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism.
Thrombosis and haemostasis 1997;77(6):1164-7.
1997: MT Nurmohamed; Hugo ten Cate; JW ten Cate
Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations.
Drugs 1997;53(5):736-51.
1997: R J Beijering; Hugo ten Cate; MT Nurmohamed; JW ten Cate
Anticoagulants and extracorporeal circuits.
Seminars in thrombosis and hemostasis 1997;23(2):225-33.
1997: Marcel Levi; Tom van der Poll; Hugo ten Cate; Sander J H van Deventer
The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia.
European journal of clinical investigation 1997;27(1):3-9.
1996: Hugo ten Cate; M T Nurmohamed; J W ten Cate
Developments in antithrombotic therapy: state of the art anno 1996.
Pharmacy world & science : PWS 1996;18(6):195-203.
1996: W A Wuillemin; C Erik Hack; W K Bleeker; Bart J Biemond; Marcel Levi; Hugo ten Cate
Inactivation of factor Xia in vivo: studies in chimpanzees and in humans.
Thrombosis and haemostasis 1996;76(4):549-55.
1996: W A Wuillemin; W K Bleeker; J Agterberg; G Rigter; Hugo ten Cate; C Erik Hack
Clearance of human factor XIa-inhibitor complexes in rats.
British journal of haematology 1996;93(4):950-4.
1996: W A Wuillemin; Eric Eldering; Franca Citarella; C P de Ruig; Hugo ten Cate; C Erik Hack
Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa.
The Journal of biological chemistry 1996;271(22):12913-8.
1996: R J Beijering; Hugo ten Cate; JW ten Cate
Clinical applications of new antithrombotic agents.
Annals of hematology 1996;72(4):177-83.
1996: Hugo ten Cate; Bart J Biemond; Marcel Levi; W A Wuillemin; Kenneth A Bauer; S Barzegar; H R Buller; C Erik Hack; JW ten Cate; R D Rosenberg
Factor XIa induced activation of the intrinsic cascade in vivo.
Thrombosis and haemostasis 1996;75(3):445-9.
1996: W A Wuillemin; Koen Mertens; Hugo ten Cate; C Erik Hack
Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombin.
British journal of haematology 1996;92(2):466-72.
1996: Tom van der Poll; J Jansen; Marcel Levi; Hugo ten Cate; C Erik Hack; Lucien A Aarden; JW ten Cate; Sander J H van Deventer
Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.
Scandinavian journal of immunology 1996;43(1):122-5.
1995: W A Wuillemin; Karin Fijnvandraat; B H Derkx; Marjolein Peters; W Vreede; Hugo ten Cate; C Erik Hack
Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock.
Thrombosis and haemostasis 1995;74(6):1436-41.
1995: H J Wolters; Hugo ten Cate; L L Thomas; D P M Brandjes; A van der Ende; Y van der Heiden; L W Statius van Eps
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?
British journal of haematology 1995;90(3):715-7.
1995: Bart J Biemond; Marcel Levi; Hugo ten Cate; Tom van der Poll; Harry R Büller; C Erik Hack; JW ten Cate
Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
Clinical science (London, England : 1979) 1995;88(5):587-94.
1995: Tom van der Poll; Marcel Levi; Hugo ten Cate; J Jansen; Bart J Biemond; B L Haagmans; A Eerenberg; Sander J H van Deventer; C Erik Hack; JW ten Cate
Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.
Clinical and experimental immunology 1995;100(1):21-5.
1995: W A Wuillemin; MC Minnema; Joost C M Meijers; D Roem; A J Eerenberg; J H Nuijens; Hugo ten Cate; C Erik Hack
Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.
Blood 1995;85(6):1517-26.
1995: Bart J Biemond; Marcel Levi; Hugo ten Cate; H R Soule; L D Morris; D L Foster; C A Bogowitz; Tom van der Poll; Harry R Büller; JW ten Cate
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
Thrombosis and haemostasis 1995;73(2):223-30.
1995: J Jansen; Tom van der Poll; Marcel Levi; Hugo ten Cate; H Gallati; JW ten Cate; Sander J H van Deventer
Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-alpha antibody.
Journal of clinical immunology 1995;15(1):45-50.
1994: Tom van der Poll; J Jansen; Marcel Levi; Hugo ten Cate; JW ten Cate; Sander J H van Deventer
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees.
The Journal of experimental medicine 1994;180(5):1985-8.
1994: Hugo ten Cate; B E Schenk; Bart J Biemond; Marcel Levi; Tom van der Poll; H R Buller; JW ten Cate
A review of studies of the activation of the blood coagulation mechanism in chimpanzees (Pan troglodytes).
Journal of medical primatology 1994;23(5):280-4.
1994: Tom van der Poll; Marcel Levi; C Erik Hack; Hugo ten Cate; Sander J H van Deventer; A J Eerenberg; Els R de Groot; J Jansen; H Gallati; Harry R Büller
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
The Journal of experimental medicine 1994;179(4):1253-9.
1994: Tom van der Poll; Sander J H van Deventer; Hugo ten Cate; Marcel Levi; JW ten Cate
Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.
The Journal of infectious diseases 1994;169(3):665-7.
1994: B Kuipers; Tom van der Poll; Marcel Levi; Sander J H van Deventer; Hugo ten Cate; Y Imai; C Erik Hack; JW ten Cate
Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2438-46.
1994: M Peters; B E Plaat; Hugo ten Cate; H J Wolters; R S Weening; D P M Brandjes
Enhanced thrombin generation in children with sickle cell disease.
Thrombosis and haemostasis 1994;71(2):169-72.
1994: Tom van der Poll; Marcel Levi; Sander J H van Deventer; Hugo ten Cate; B L Haagmans; Bart J Biemond; Harry R Büller; C Erik Hack; JW ten Cate
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
Blood 1994;83(2):446-51.
1994: Marcel Levi; Hugo ten Cate; K A Bauer; Tom van der Poll; T S Edgington; Harry R Büller; Sander J H van Deventer; C Erik Hack; JW ten Cate; R D Rosenberg
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
The Journal of clinical investigation 1994;93(1):114-20.
1994: Tom van der Poll; Marcel Levi; Hugo ten Cate; Sander J H van Deventer
The role of tumor necrosis factor in systemic inflammatory responses in primate endotoxemia.
Progress in clinical and biological research 1994;388():425-33.
1994: Hugo ten Cate; Marcel Levi; Tom van der Poll; Bart J Biemond; Sander J H van Deventer; H R Buller; JW ten Cate
Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications.
Progress in clinical and biological research 1994;388():215-9.
1993: Tom van der Poll; J Jansen; D van Leenen; M von der Möhlen; Marcel Levi; Hugo ten Cate; H Gallati; JW ten Cate; Sander J H van Deventer
Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
The Journal of infectious diseases 1993;168(4):955-60.
1993: Hugo ten Cate; Kenneth A Bauer; Marcel Levi; T S Edgington; R D Sublett; S Barzegar; B L Kass; R D Rosenberg
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.
The Journal of clinical investigation 1993;92(3):1207-12.
1993: D van Leenen; Tom van der Poll; Marcel Levi; Hugo ten Cate; Sander J H van Deventer; C Erik Hack; Lucien A Aarden; JW ten Cate
Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(4):2318-25.
1993: Hugo ten Cate; D P M Brandjes; H J Wolters; Sander J H van Deventer
Disseminated intravascular coagulation: pathophysiology, diagnosis, and treatment.
New horizons (Baltimore, Md.) 1993;1(2):312-23.
1992: Y G Caine; Kenneth A Bauer; S Barzegar; Hugo ten Cate; F M Sacks; B W Walsh; I Schiff; R D Rosenberg
Coagulation activation following estrogen administration to postmenopausal women.
Thrombosis and haemostasis 1992;68(4):392-5.
1992: Kenneth A Bauer; Pier M Mannucci; Alessandro Gringeri; F Tradati; S Barzegar; B L Kass; Hugo ten Cate; A S Kestin; D B Brettler; R D Rosenberg
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.
Blood 1992;79(8):2039-47.
1992: J A Hoek; M T Nurmohamed; K J Hamelynck; R K Marti; H C Knipscheer; Hugo ten Cate; Harry R Büller; H N Magnani; JW ten Cate
Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid.
Thrombosis and haemostasis 1992;67(1):28-32.
1991: J A Hoek; C P Henny; H C Knipscheer; Hugo ten Cate; M T Nurmohamed; JW ten Cate
The effect of different anaesthetic techniques on the incidence of thrombosis following total hip replacement.
Thrombosis and haemostasis 1991;65(2):122-5.
1990: Kenneth A Bauer; B L Kass; Hugo ten Cate; Jacek Hawiger; R D Rosenberg
Factor IX is activated in vivo by the tissue factor mechanism.
Blood 1990;76(4):731-6.
1990: Tom van der Poll; Harry R Büller; Hugo ten Cate; C H Wortel; K A Bauer; Sander J H van Deventer; C Erik Hack; Hans P Sauerwein; R D Rosenberg; JW ten Cate
Activation of coagulation after administration of tumor necrosis factor to normal subjects.
The New England journal of medicine 1990;322(23):1622-7.
1989: Kenneth A Bauer; B L Kass; Hugo ten Cate; M A Bednarek; Jacek Hawiger; R D Rosenberg
Detection of factor X activation in humans.
Blood 1989;74(6):2007-15.
1989: Kenneth A Bauer; Hugo ten Cate; S Barzegar; David Spriggs; M L Sherman; R D Rosenberg
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans.
Blood 1989;74(1):165-72.
1989: V P van der Hulst; C P Henny; Adriaan C Moulijn; G Engbers; Hugo ten Cate; P F Gründeman; P J Klopper
Veno-venous bypass without systemic heparinization using a centrifugal pump: a blind comparison of a heparin bonded circuit versus a non heparin bonded circuit.
The Journal of cardiovascular surgery 1989;30(1):118-23.
1988: Hugo ten Cate; C P Henny; J W ten Cate; H R Büller
Clinical studies with low-molecular-weight heparin(oid)s: an interim analysis.
American journal of hematology 1988;27(2):146-53.
1987: Hugo ten Cate; C P Henny; JW ten Cate; H R Büller; Noshir Framroze Dabhoiwala
Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate.
Thrombosis and haemostasis 1987;57(1):92-6.
1986: C P Henny; Hugo ten Cate; J W ten Cate; M F Prummel; M Peters; H R Büller
Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular weight heparinoid.
Thrombosis and haemostasis 1986;55(2):301.
1986: C P Henny; J A Odoom; Hugo ten Cate; JW ten Cate; R J Oosterhoff; Noshir Framroze Dabhoiwala; I L Sih
Effects of extradural bupivacaine on the haemostatic system.
British journal of anaesthesia 1986;58(3):301-5.
1985: C P Henny; Hugo ten Cate; Sugianto Surachno; P Stevens; H R Büller; M den Hartog; J W ten Cate
The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis.
Thrombosis and haemostasis 1985;54(2):460-2.
1985: C P Henny; Hugo ten Cate; J W Ten Cate; Adriaan C Moulijn; T H Sie; P Warren; H R Büller
A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
The Journal of laboratory and clinical medicine 1985;106(2):187-96.
1985: Hugo ten Cate; C P Henny; J W ten Cate; H R Büller; M C Mooy; Sugianto Surachno; J M Wilmink
Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
Thrombosis research 1985;39(2):211-22.
1984: Hugo ten Cate; R J Lamping; C P Henny; A Prins; J W ten Cate
Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity.
Clinical chemistry 1984;30(6):860-4.
1984: Hugo ten Cate; C P Henny; H R Büller; J W Ten Cate; H N Magnani
Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease.
Annals of neurology 1984;15(3):268-70.
1984: C P Henny; Hugo ten Cate; Noshir Framroze Dabhoiwala; H R Büller; JW ten Cate
Effect of hormonal manipulation on antithrombin III activity in patients with prostatic carcinoma.
European urology 1984;10(3):202-6.
1983: C P Henny; Hugo ten Cate; J W Ten Cate; Sugianto Surachno; H van Bronswijk; J M Wilmink; P A Ockelford
Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications.
Lancet 1983;1(8330):890-3.
1982: C P Henny; Hugo ten Cate; H R Büller; J W ten Cate
Ambulatory heparin treatment.
Lancet 1982;1(8272):615.